MedTrace Logo

Angiotensinogen Variants and Adverse Pregnancy Outcomes

NCT00005400 · Status: COMPLETED · Type: OBSERVATIONAL

Last updated 2016-01-21

No results posted yet for this study

Summary

To examine angiotensinogen genetic variants and adverse pregnancy outcomes.

Conditions

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • University of Utah

    lead OTHER

Principal Investigators

  • Kenneth Ward · University of Utah

Eligibility

Max Age
100 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1995-08-31
Completion
2003-07-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00005400 on ClinicalTrials.gov